UK health regulator approves Moderna's RSV vaccine for people aged 60 and over
Britain's health regulator said on Friday it has approved Moderna's vaccine to protect patients aged 60 and over against ...
Stocktwits on MSN3h
Moderna Stock Heads For Weekly Loss As Retail Caution Prevails: Wealth Advisor Tells Why She's Staying On The Sidelines
Shares of Moderna Inc. (MRNA) are on track for a more than 12% weekly decline, with sentiment among retail traders turning ...
Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Outlook Disappoints
Moderna reported a wider loss than expected for the fourth quarter on Friday morning, and the drugmaker's sales forecast for ...
Moderna to Present at Upcoming Conferences in March 2025
Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...
Moderna's Q4 Loss Wider Than Expected
The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 ...
UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
These Stocks Moved the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More
Nvidia reports better-than-expected fourth-quarter earnings as revenue jumps 78% on demand for the company’s ...